{"id":784481,"date":"2026-05-09T15:08:13","date_gmt":"2026-05-09T15:08:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/784481\/"},"modified":"2026-05-09T15:08:13","modified_gmt":"2026-05-09T15:08:13","slug":"nh-surgeon-on-rise-in-the-use-of-glp-1-medication-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/784481\/","title":{"rendered":"NH surgeon on rise in the use of GLP-1 medication for weight loss"},"content":{"rendered":"<p>NH surgeon discusses rise in the use of GLP-1 medication for weight loss<\/p>\n<p>Pros and cons of using GLP-1 medications for weight loss, NH doctor weighs in<\/p>\n<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\tHAVE TO GET THEIR VEHICLES INSPECTED. THERE HAS BEEN A RISE IN THE USE OF GLP ONE FOR WEIGHT LOSS. CELEBRITIES AND INFLUENCERS HAVE COME OUT DOCUMENTING THEIR EXPERIENCE AS THEY SHARE THEIR WEIGHT LOSS JOURNEYS. BUT THIS NEW TREND HAS ALSO BROUGHT UP SOME QUESTIONS REGARDING THE LONG TERM EFFECTS AND OVERALL SAFETY OF GLP ONE. TO HELP GIVE US A BETTER PERSPECTIVE ON GLP ONE, WE ARE BRINGING IN DOCTOR ROBERT CATANIA, A SURGEON AT SOUTHERN NEW HAMPSHIRE WEIGHT MANAGEMENT. HE IS AN EXPERT ON WEIGHT LOSS. GLP ONE SURGERIES AND STRATEGIES. GOOD MORNING DOCTOR. THANKS SO MUCH FOR JOINING US. LET\u2019S DIVE RIGHT IN. WHAT ABOUT WHAT ABOUT GLP ONE AND AIDING WEIGHT LOSS. ITS INTENTIONAL USE IS TO HELP PEOPLE WITH DIABETES. IS THAT CORRECT? CORRECT. IT WAS FIRST DISCOVERED IN THE 90S AND THEN IT STARTED USED IN THE EARLY 2000 FOR DIABETES. IT WAS FOUND TO HAVE A BENEFIT TO WEIGHT MANAGEMENT AS WELL. THROUGH THOSE DIABETES USES. AND SO IN THE MID MID 20 TENS, WE STARTED USING IT FOR WEIGHT MANAGEMENT AS WELL. AND FROM WHAT I UNDERSTAND, IT\u2019S BEEN VERY SUCCESSFUL. BUT THERE ARE PROS AND CONS THAT COME TO USING THIS WEIGHT LOSS MEDICATION. CAN YOU GO INTO THOSE PLEASE. SURE. ABSOLUTELY. SO ALL MEDICATIONS HAVE PROS AND CONS. WHEN YOU USE THE RIGHT MEDICATION FOR THE RIGHT PATIENT, IT CAN OFTEN BE VERY SUCCESSFUL. SO THE BENEFITS ARE IMPROVED. DIABETES MANAGEMENT IMPROVED WEIGHT MANAGEMENT. IT ACTUALLY HELPS WITH OBSTRUCTIVE SLEEP APNEA. IT CAN HELP WITH LOWERING CARDIOVASCULAR RISK. SO LOTS OF GOOD THINGS ABOUT USING THE MEDICATION. CONS IT CAN HAVE SOME GI SIDE EFFECTS. AND ALSO IT\u2019S USED BY THE WRONG PATIENTS. OR IF THE PATIENTS DON\u2019T USE THE RIGHT DIET AND EXERCISE PROGRAM IN CONJUNCTION WITH THE MEDICATION, IT CAN CAUSE PROBLEMS LIKE MUSCLE WASTING, GASTROPARESIS, THINGS THAT YOU REALLY WANT TO TRY TO AVOID. IF YOU USE THE MEDICATION PROPERLY. AND THERE HAS BEEN A LOT OF SIDE EFFECTS COMING OUT FROM INFLUENCERS AND OTHER PEOPLE WHO ARE ON IT. I\u2019VE HEARD OF GLP ONE BREATH AS WELL AS IT POTENTIALLY CAUSING PROTEIN DEFICIENCIES AND HOLLOW CHEEKBONES. ARE THESE ALSO REAL SIDE EFFECTS? YEAH, THEY CAN OCCUR. I WOULD CALL THEM MORE. THE RESULTS OF MISUSE OF THE MEDICATION. HOWEVER, I THINK IT\u2019S REALLY IMPORTANT WHEN YOU\u2019RE ON A MEDICATION LIKE THIS THAT\u2019S SO POWERFUL THAT YOU\u2019RE BEING CAREFULLY MONITORED BY A HEALTHCARE TEAM SO THAT YOU\u2019RE MAKING SURE YOU\u2019RE GETTING ENOUGH PROTEIN, GETTING ENOUGH VITAMINS, AND YOU UNDERSTAND WHY SOME OF THESE CHANGES ARE OCCURRING. SO YOU CAN COUNTER THEM IF THEY OCCUR EARLIER, THAT SOME PEOPLE ARE BETTER SUITED THAN OTHERS FOR THIS MEDICATION. WHO ARE, WHO ARE THE PEOPLE WHO ARE REALLY WELL SUITED TO BE ON GLP ONES? SO THE FDA SAYS ANYONE WITH A BODY MASS INDEX GREATER THAN 27 WHO HAS MEDICAL RELATED PROBLEMS ASSOCIATED WITH OBESITY, LIKE HIGH BLOOD PRESSURE OR DIABETES, SHOULD BE USING THE MEDICATIONS OR ANYONE WITH A BODY MASS INDEX OVER 30 CAN ALSO USE THIS FOR WEIGHT LOSS. IT\u2019S NOT REALLY DESIGNED AND PROBABLY SHOULDN\u2019T BE USED FOR PEOPLE WHO ARE TRYING TO LOSE 5 OR 10 POUNDS. ALL RIGHT.\n\t\t\t\t\t\t\t\t\t\t\t<\/p>\n<p>NH surgeon discusses rise in the use of GLP-1 medication for weight loss<\/p>\n<p>Pros and cons of using GLP-1 medications for weight loss, NH doctor weighs in<\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/wmur.png\" class=\"lazyload lazyload-in-view branding\" alt=\"WMUR logo\"\/><\/p>\n<p>\n\t\t\tUpdated: 10:59 AM EDT May 9, 2026\n\t\t<\/p>\n<p>\t\t<a href=\"https:\/\/www.wmur.com\/article\/hearst-television-news-policy-statements\/14471973\" class=\"editorial-standards border-left\" rel=\"nofollow noopener\" target=\"_blank\">Editorial Standards \u24d8<\/a><\/p>\n<p>\n\t\t\t\t\t\tWMUR&#8217;s Alanna Flood speaks with Doctor Robert Catania, surgeon at Southern New Hampshire Weight Management, about GLP-1 medication.\n\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t\t<strong class=\"dateline\">MANCHESTER, N.H. \u2014<\/strong> \t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n<p>WMUR&#8217;s Alanna Flood speaks with Doctor Robert Catania, surgeon at Southern New Hampshire Weight Management, about GLP-1 medication.<\/p>\n","protected":false},"excerpt":{"rendered":"NH surgeon discusses rise in the use of GLP-1 medication for weight loss Pros and cons of using&hellip;\n","protected":false},"author":3,"featured_media":784482,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[320872,9223,320873,3654,94791,210,30570,1815,1060,991,320871,26527,193410,67,132,68,20175,428,91754],"class_list":{"0":"post-784481","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-alanna-flood","9":"tag-doctor","10":"tag-doctor-robert-catania","11":"tag-glp-1","12":"tag-glp-1-medication","13":"tag-health","14":"tag-increase","15":"tag-interview","16":"tag-medication","17":"tag-new-hampshire","18":"tag-nh-surgeon","19":"tag-rise","20":"tag-surgeon","21":"tag-united-states","22":"tag-unitedstates","23":"tag-us","24":"tag-use","25":"tag-weight-loss","26":"tag-wmur"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116545251584907782","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/784481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=784481"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/784481\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/784482"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=784481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=784481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=784481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}